Literature DB >> 10569934

Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

K Hasegawa1, I Yamaguchi, S Omata, F Gejyo, H Naiki.   

Abstract

We analyzed the interaction of two kinds of amyloid beta-peptides (A beta), i.e., A beta(1-42) and A beta(1-40), in the kinetics of beta-amyloid fibril (fA beta) formation in vitro, based on a nucleation-dependent polymerization model using fluorescence spectroscopy with thioflavin T. When 25 microM A beta(1-42) was incubated with increasing concentrations of amyloidogenic A beta(1-40), the time to proceed to equilibrium was extended dose-dependently. A similar inhibitory effect was observed when 45 microM A beta(1-40) was incubated with increasing concentrations of A beta(1-42). On the other hand, when 50 microM of nonamyloidogenic A beta(1-40) was incubated with A beta(1-42) at a molar ratio of 10:1 or 5:1, A beta(1-42) initiated fA beta formation from A beta(1-40). The lag time of the reaction shortened in a concentration-dependent manner, with A beta(1-42). We next examined the seeding effect of fA beta formed from A beta(1-42) (fA beta(1-42)) on nonamyloidogenic A beta(1-40). When 50 microM of nonamyloidogenic A beta(1-40) was incubated with 10 or 20 microg/mL (2.2 or 4.4 microM) of fA beta(1-42), the fluorescence showed a sigmoidal increase. The lag time of the reaction was shortened by fA beta(1-42) in a concentration-dependent manner. However, the time to proceed to equilibrium was much longer than when an equal concentration of fA beta formed from A beta(1-40) (fA beta(1-40)) was added to A beta(1-40). The fluorescence increased hyperbolically without a lag phase when 25 microM A beta(1-42) was incubated with 10 or 20 microg/mL (2.3 or 4.6 microM) of fA beta(1-40), and proceeded to equilibrium more rapidly than without fA beta(1-40). An electron microscopic study indicated that the morphology of fA beta formed is governed by the major component of fresh A beta peptides in the reaction mixture, not by the morphology of preexisting fibrils. These results may indicate the central role of A beta(1-42) for fA beta deposition in vivo, among the different coexisting A beta species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569934     DOI: 10.1021/bi991161m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  Observations in APP bitransgenic mice suggest that diffuse and compact plaques form via independent processes in Alzheimer's disease.

Authors:  Anna Lord; Ola Philipson; Therése Klingstedt; Gunilla Westermark; Per Hammarström; K Peter R Nilsson; Lars N G Nilsson
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.

Authors:  Naruhiko Sahara; Jada Lewis
Journal:  Future Neurol       Date:  2010-05-01

3.  A statistical-mechanical theory of fibril formation in dilute protein solutions.

Authors:  Jeroen van Gestel; Simon W de Leeuw
Journal:  Biophys J       Date:  2006-05-01       Impact factor: 4.033

4.  Amyloid-beta peptide Abetap3-42 affects early aggregation of full-length Abeta1-42.

Authors:  Hiromi M Sanders; Robert Lust; Jan K Teller
Journal:  Peptides       Date:  2009-02-11       Impact factor: 3.750

5.  The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.

Authors:  Asad Jan; Ozgun Gokce; Ruth Luthi-Carter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

6.  Differences in β-strand populations of monomeric Aβ40 and Aβ42.

Authors:  K Aurelia Ball; Aaron H Phillips; David E Wemmer; Teresa Head-Gordon
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

7.  Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.

Authors:  Ipek Baysal; Gulberk Ucar; Merve Gultekinoglu; Kezban Ulubayram; Samiye Yabanoglu-Ciftci
Journal:  J Neural Transm (Vienna)       Date:  2016-02-24       Impact factor: 3.575

8.  Interaction of selegiline-loaded PLGA-b-PEG nanoparticles with beta-amyloid fibrils.

Authors:  Ipek Baysal; Samiye Yabanoglu-Ciftci; Yeliz Tunc-Sarisozen; Kezban Ulubayram; Gulberk Ucar
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

9.  Branching in amyloid fibril growth.

Authors:  Christian Beyschau Andersen; Hisashi Yagi; Mauro Manno; Vincenzo Martorana; Tadato Ban; Gunna Christiansen; Daniel Erik Otzen; Yuji Goto; Christian Rischel
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

10.  Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.

Authors:  Kiyotaka Tokuraku; Meg Marquardt; Tsuneya Ikezu
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.